Panacur

Verify with FDA CVM →

89 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
89
Total Reports
5
Deaths Reported
560.0%
Death Rate

Active Ingredients

Panacur

Administration Routes

OralUnknownOther

Species Affected

Dog 72
Cat 9
Horse 4
Cattle 2
Rabbit 1
Deer 1

Most Affected Breeds

Retriever - Labrador 9
Crossbred Canine/dog 7
Domestic Shorthair 6
Greyhound 5
Retriever - Golden 5
Beagle 4
Terrier - Bull - American Pit 3
Mountain Dog - Bernese 3
Schnauzer - Miniature 3
Shepherd Dog - Australian 3

Most Reported Reactions

Lack of efficacy (endoparasite) - hookworm 27
Lack of efficacy (endoparasite) - roundworm NOS 17
Diarrhoea 10
Vomiting 10
Leucocytosis NOS 7
Lethargy (see also Central nervous system depression in Neurological) 7
Other abnormal test result NOS 5
Decreased haematocrit 5
Bloody diarrhoea 4
Lack of efficacy (endoparasite) - tapeworm 4
Increased band neutrophilia 4
Lack of efficacy (endoparasite) - strongylids 4

Outcome Breakdown

Ongoing
52 (58.4%)
Recovered/Normal
19 (21.3%)
Outcome Unknown
13 (14.6%)
Euthanized
3 (3.4%)
Died
2 (2.2%)

Data Summary

Metric Value
Total adverse event reports 89
Reports involving death 5
Case-fatality rate (reported events) 560.0%
Distinct species in reports 6
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Panacur Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 89 adverse event reports referencing Panacur, including 5 reports in which the animal died — a 560.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Panacur. Reported administration routes include Oral, Unknown, Other. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Panacur reports are Dog (72 reports), Cat (9 reports), Horse (4 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (9), Crossbred Canine/dog (7), Domestic Shorthair (6) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Panacur are Lack of efficacy (endoparasite) - hookworm (27), Lack of efficacy (endoparasite) - roundworm NOS (17), Diarrhoea (10), Vomiting (10). Of the 89 reports with a coded outcome, Ongoing is the leading category at 58.4%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Panacur.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial